149 related articles for article (PubMed ID: 25832818)
1. Integrated copy number and gene expression profiling analysis of Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Yoon H; Park S; Ju H; Ha SY; Sohn I; Jo J; Do IG; Min S; Kim SJ; Kim WS; Yoo HY; Ko YH
Genes Chromosomes Cancer; 2015 Jun; 54(6):383-96. PubMed ID: 25832818
[TBL] [Abstract][Full Text] [Related]
2. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
3. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.
Cohen M; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Int J Cancer; 2014 Dec; 135(12):2816-24. PubMed ID: 24789501
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) provides survival factors to EBV
Wu L; Ehlin-Henriksson B; Zhou X; Zhu H; Ernberg I; Kis LL; Klein G
Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.
Adam P; Bonzheim I; Fend F; Quintanilla-Martínez L
Adv Anat Pathol; 2011 Sep; 18(5):349-55. PubMed ID: 21841405
[TBL] [Abstract][Full Text] [Related]
10. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
Quan L; Chen X; Liu A; Zhang Y; Guo X; Yan S; Liu Y
PLoS One; 2015; 10(9):e0136476. PubMed ID: 26361042
[TBL] [Abstract][Full Text] [Related]
11. The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.
Healy JA; Dave SS
Curr Top Microbiol Immunol; 2015; 390(Pt 1):315-37. PubMed ID: 26424652
[TBL] [Abstract][Full Text] [Related]
12. EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.
Ferreiro JF; Morscio J; Dierickx D; Vandenberghe P; Gheysens O; Verhoef G; Zamani M; Tousseyn T; Wlodarska I
Am J Transplant; 2016 Feb; 16(2):414-25. PubMed ID: 26780579
[TBL] [Abstract][Full Text] [Related]
13. Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?
Ok CY; Ye Q; Li L; Manyam GC; Deng L; Goswami RR; Wang X; Montes-Moreno S; Visco C; Tzankov A; Dybkaer K; Zhang L; Abramson J; Sohani AR; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhang S; Parsons BM; Xu M; Møller MB; Winter JN; Piris MA; Xu-Monette ZY; Medeiros LJ; Young KH
Oncotarget; 2015 Jun; 6(16):13933-45. PubMed ID: 26101854
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways.
Kato H; Karube K; Yamamoto K; Takizawa J; Tsuzuki S; Yatabe Y; Kanda T; Katayama M; Ozawa Y; Ishitsuka K; Okamoto M; Kinoshita T; Ohshima K; Nakamura S; Morishima Y; Seto M
Cancer Sci; 2014 May; 105(5):537-44. PubMed ID: 24581222
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
Lu TX; Liang JH; Miao Y; Fan L; Wang L; Qu XY; Cao L; Gong QX; Wang Z; Zhang ZH; Xu W; Li JY
Sci Rep; 2015 Jul; 5():12168. PubMed ID: 26202875
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of EBV associated diffuse large B-cell lymphoma.
Frontzek F; Staiger AM; Wullenkord R; Grau M; Zapukhlyak M; Kurz KS; Horn H; Erdmann T; Fend F; Richter J; Klapper W; Lenz P; Hailfinger S; Tasidou A; Trautmann M; Hartmann W; Rosenwald A; Quintanilla-Martinez L; Ott G; Anagnostopoulos I; Lenz G
Leukemia; 2023 Mar; 37(3):670-679. PubMed ID: 36604606
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ
Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
19. In Europe expression of EBNA2 is associated with poor survival in EBV-positive diffuse large B-cell lymphoma of the elderly.
Stuhlmann-Laeisz C; Borchert A; Quintanilla-Martinez L; Hoeller S; Tzankov A; Oschlies I; Kreuz M; Trappe R; Klapper W
Leuk Lymphoma; 2016; 57(1):39-44. PubMed ID: 25899404
[TBL] [Abstract][Full Text] [Related]
20. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
Keane C; Tobin J; Gunawardana J; Francis S; Gifford G; Gabrielli S; Gill A; Stevenson W; Talaulikar D; Gould C; Jain S; Birch S; Hertzberg M; Gandhi MK
Eur J Haematol; 2019 Sep; 103(3):200-207. PubMed ID: 31211907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
